Da-Feng Lin

434 total citations
11 papers, 275 citations indexed

About

Da-Feng Lin is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Da-Feng Lin has authored 11 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Otorhinolaryngology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Da-Feng Lin's work include Head and Neck Cancer Studies (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Head and Neck Surgical Oncology (3 papers). Da-Feng Lin is often cited by papers focused on Head and Neck Cancer Studies (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Head and Neck Surgical Oncology (3 papers). Da-Feng Lin collaborates with scholars based in China and United States. Da-Feng Lin's co-authors include Suli Huang, Huan Guo, Xiaomin Zhang, Xiaohai Li, Meian He, Yingying Feng, Wangzhen Zhang, Xiayun Dai, Qifei Deng and Lin‐Quan Tang and has published in prestigious journals such as Nature Communications, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Da-Feng Lin

11 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Da-Feng Lin China	6	74	71	63	55	45	11	275
David Zaridze France	5	58 0.8×	40 0.6×	30 0.5×	49 0.9×	65 1.4×	5	235
Anuj Tharakan United States	12	87 1.2×	109 1.5×	34 0.5×	40 0.7×	15 0.3×	20	395
Brenda Sweeney United States	9	64 0.9×	26 0.4×	95 1.5×	73 1.3×	55 1.2×	21	390
Xiaoping Lai China	10	129 1.7×	12 0.2×	21 0.3×	22 0.4×	23 0.5×	31	280
Oriol Mirallas Spain	8	9 0.1×	10 0.1×	98 1.6×	29 0.5×	20 0.4×	35	225
Douglas Easton United Kingdom	6	21 0.3×	12 0.2×	22 0.3×	44 0.8×	45 1.0×	7	200
Yongqiang Yang China	10	10 0.1×	7 0.1×	70 1.1×	60 1.1×	83 1.8×	43	400
Brody Ar United States	9	6 0.1×	76 1.1×	24 0.4×	234 4.3×	33 0.7×	12	331
Yang Peng China	11	76 1.0×	11 0.2×	7 0.1×	101 1.8×	8 0.2×	24	277
Avinaash Korrapati United States	9	30 0.4×	52 0.7×	19 0.3×	22 0.4×	150 3.3×	12	417

Countries citing papers authored by Da-Feng Lin

Since Specialization

Citations

This map shows the geographic impact of Da-Feng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da-Feng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da-Feng Lin more than expected).

Fields of papers citing papers by Da-Feng Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Da-Feng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da-Feng Lin. The network helps show where Da-Feng Lin may publish in the future.

Co-authorship network of co-authors of Da-Feng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Da-Feng Lin. A scholar is included among the top collaborators of Da-Feng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Da-Feng Lin. Da-Feng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Lin, Da-Feng, Hailin Li, Ting Liu, et al.. (2024). Radiomic signatures associated with tumor immune heterogeneity predict survival in locally recurrent nasopharyngeal carcinoma. JNCI Journal of the National Cancer Institute. 116(8). 1294–1302. 14 indexed citations

Li, Yuan, Xiaofei Lv, Da-Feng Lin, et al.. (2023). Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial. Nature Communications. 14(1). 4893–4893. 25 indexed citations

Li, Su‐Chen, Xuesong Sun, Da-Feng Lin, et al.. (2023). A new prognostic model for predicting outcomes of patients with recurrent or metastatic nasopharyngeal carcinoma receiving subsequent line (≥2 lines) anti-programmed death-1 monotherapy. Oral Oncology. 139. 106336–106336. 3 indexed citations

Xie, Hao‐Jun, Xue-Song Sun, Xu Zhang, et al.. (2023). Head and neck MRI-based T stage and [18F]FDG PET/CT-based N/M stage improved prognostic stratification in primary nasopharyngeal carcinoma. European Radiology. 33(11). 7952–7966. 3 indexed citations

Zhang, Ming, et al.. (2023). Association of p-phenylenediamine exposure with alterations of pulmonary function, pruritus and health-related quality of life in hair dye factory workers: a cross-sectional study. Scientific Reports. 13(1). 2623–2623. 5 indexed citations

Yan, Jin‐Jie, Shanshan Guo, Da-Feng Lin, et al.. (2021). Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma. Radiotherapy and Oncology. 160. 9–17. 1 indexed citations

Chen, Xiaohong, Wei Liu, Lu Wang, et al.. (2020). Diabetes mellitus is associated with elevated urinary pyrrole markers of γ-diketones known to cause axonal neuropathy. BMJ Open Diabetes Research & Care. 8(1). e001575–e001575. 3 indexed citations

Sun, Xue-Song, Sai‐Lan Liu, Xiaoyun Li, et al.. (2019). The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012. International Journal of Radiation Oncology*Biology*Physics. 105(3). 581–590. 79 indexed citations

Li, Anming, Da-Feng Lin, Wei Zhang, et al.. (2019). Association of survival and blood-based genomic signature with atezolizumab for patients with second-line and third-line EGFR wild-type non-small cell lung cancer: Pooled analysis of individual patient data from the POPLAR and OAK trials. Annals of Oncology. 30. ix107–ix107. 2 indexed citations

10.

Yang, Binyao, Qifei Deng, Wangzhen Zhang, et al.. (2016). Exposure to Polycyclic Aromatic Hydrocarbons, Plasma Cytokines and Heart Rate Variability. Scientific Reports. 6(1). 19272–19272. 24 indexed citations

11.

Li, Xiaohai, Yingying Feng, Huaxin Deng, et al.. (2012). The Dose–Response Decrease in Heart Rate Variability: Any Association with the Metabolites of Polycyclic Aromatic Hydrocarbons in Coke Oven Workers?. PLoS ONE. 7(9). e44562–e44562. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact